The MalaCard for "hamartoma" has been retired.
Searching MalaCards for entries containing "hamartoma"
Searching MalaCards for entries containing "hamartoma"
334 hits were found for 'hamartoma'
| # | F | MCID | Name | MIFTS | Score |
|---|---|---|---|---|---|
| 1 | CWD001 | Cowden Disease | 67.3 | 4.917 | |
| 2 | HYP231 | Hypothalamic Hamartomas | 41.1 | 3.771 | |
| 3 | RNL041 | Renal Hamartomas Nephroblastomatosis and Fetal Gigantism | 5.0 | 3.638 | |
| 4 | GNT022 | Giant Mammary Hamartoma | 2.0 | 3.611 | |
| 5 | c | PTN003 | Pten Hamartoma Tumor Syndrome (phts) | 8.0 | 3.596 |
| 6 | LNR002 | Linear Hamartoma Syndrome | 7.8 | 3.270 | |
| 7 | P | PTN006 | Pten Hamartoma Tumor Syndrome | 9.9 | 3.202 |
| 8 | MCR030 | Macrocephaly Mesodermal Hamartoma Spectrum | 2.0 | 3.151 | |
| 9 | HYP277 | Hypothalamic Hamartomas, Somatic | 10.8 | 3.136 | |
| 10 | ANG033 | Angiomyomatous Hamartoma | 0.0 | 3.119 | |
| 11 | BNN001 | Bannayan-riley-ruvalcaba Syndrome | 42.0 | 2.732 | |
| 12 | PRT008 | Proteus Syndrome | 45.9 | 2.732 | |
| 13 | PTZ001 | Peutz-jeghers Syndrome | 70.2 | 2.732 | |
| 14 | BSL013 | Basaloid Follicular Hamartoma | 6.0 | 2.605 | |
| 15 | RHB007 | Rhabdomyomatous Mesenchymal Hamartoma | 1.0 | 2.573 | |
| 16 | ANG032 | Angiomatous Lymphoid Hamartoma | 2.0 | 2.554 | |
| 17 | HPT028 | Hepatic Cystic Hamartoma | 3.0 | 2.554 | |
| 18 | HRT016 | Heart Defect, Tongue Hamartoma and Polysyndactyly | 9.8 | 2.554 | |
| 19 | CPL006 | Capillary Hemangioma | 52.1 | 1.819 | |
| 20 | GRH002 | Graham Boyle Troxell Syndrome | 3.0 | 1.790 | |
| 21 | ORS001 | Orstavik Lindemann Solberg Syndrome | 3.0 | 1.790 | |
| 22 | CRC003 | Carcinoma | 94.8 | 0.101 | |
| 23 | ADS002 | Adie Syndrome | 29.8 | 0.094 | |
| 24 | PLL001 | Pallister-hall Syndrome | 53.6 | 0.094 | |
| 25 | PRC019 | Precocious Puberty | 65.6 | 0.094 | |
| 26 | P | TBR001 | Tuberous Sclerosis | 83.5 | 0.094 |
| 27 | AMN003 | Amnestic Disorder | 25.2 | 0.087 | |
| 28 | ART001 | Arterial Tortuosity Syndrome | 41.1 | 0.087 | |
| 29 | PRN023 | Prion Disease | 78.3 | 0.087 | |
| 30 | SBC012 | Subcorneal Pustular Dermatosis | 38.3 | 0.087 | |
| 31 | TRC078 | Trichohepatoenteric Syndrome 2 | 15.5 | 0.080 | |
| 32 | P | BSL007 | Basal Cell Carcinoma | 83.1 | 0.071 |
| 33 | FML157 | Familial Male-limited Precocious Puberty | 30.9 | 0.071 | |
| 34 | P | LFR001 | Li-fraumeni Syndrome | 76.6 | 0.071 |
| 35 | MCK005 | Mckusick-kaufman Syndrome | 37.8 | 0.071 | |
| 36 | NRN002 | Neuronitis | 82.8 | 0.071 | |
| 37 | RTN023 | Retinitis | 82.5 | 0.071 | |
| 38 | ADN016 | Adenocarcinoma | 87.0 | 0.062 | |
| 39 | ADN018 | Adenoma | 84.4 | 0.062 | |
| 40 | AND003 | Andersen-tawil Syndrome | 32.2 | 0.062 | |
| 41 | ATX002 | Ataxia Telangiectasia | 82.4 | 0.062 | |
| 42 | BRS051 | Breast Disease | 65.9 | 0.062 | |
| 43 | HMN010 | Hemangioma | 76.8 | 0.062 | |
| 44 | PLY006 | Polydactyly | 52.6 | 0.062 | |
| 45 | WST001 | West Syndrome | 44.8 | 0.062 | |
| 46 | P | 21H001 | 21-hydroxylase Deficiency | 69.3 | 0.050 |
| 47 | ACN002 | Acanthosis Nigricans | 68.0 | 0.050 | |
| 48 | ACR008 | Acrocallosal Syndrome | 38.5 | 0.050 | |
| 49 | ADR017 | Adrenal Hyperplasia | 63.1 | 0.050 | |
| 50 | ANG024 | Angiofollicular Lymph Hyperplasia | 9.6 | 0.050 | |
| 51 | ANL003 | Anal Buschke-lowenstein Tumor | 10.3 | 0.050 | |
| 52 | ATX010 | Ataxia Neuropathy Spectrum | 18.9 | 0.050 | |
| 53 | BCK002 | Beckwith-wiedemann Syndrome | 56.7 | 0.050 | |
| 54 | P | BRN019 | Bernard-soulier Syndrome | 55.7 | 0.050 |
| 55 | P | BRS047 | Breast Cancer | 101.1 | 0.050 |
| 56 | P | BRT004 | Bartter Disease | 51.5 | 0.050 |
| 57 | CNG026 | Congenital Heart Defect | 74.3 | 0.050 | |
| 58 | CNT075 | Central Precocious Puberty | 52.6 | 0.050 | |
| 59 | DBL002 | Double Outlet Right Ventricle | 48.7 | 0.050 | |
| 60 | FVL004 | Foveal Hyperplasia | 13.7 | 0.050 | |
| 61 | GGN001 | Gigantism Due to Ghrf Hypersecretion | 9.0 | 0.050 | |
| 62 | GGN002 | Gigantism | 55.9 | 0.050 | |
| 63 | GGN003 | Gigantism Advanced Bone Age Hoarse Cry | 2.0 | 0.050 | |
| 64 | GLL005 | Gallbladder Pleomorphic Giant Cell Adenocarcinoma | 8.8 | 0.050 | |
| 65 | GNT021 | Giant Ganglionic Hyperplasia | 6.9 | 0.050 | |
| 66 | GNT025 | Giant Platelet Disorder, Isolated | 8.7 | 0.050 | |
| 67 | HMF002 | Hemifacial Hyperplasia Strabismus | 10.5 | 0.050 | |
| 68 | c | HPT021 | Hepatitis | 93.1 | 0.050 |
| 69 | HPT022 | Hepatoblastoma | 72.9 | 0.050 | |
| 70 | INF114 | Infection-induced Acute Encephalopathy 3, Susceptibility to | 14.8 | 0.050 | |
| 71 | LPM004 | Lipoma | 68.5 | 0.050 | |
| 72 | PRD010 | Por Deficiency | 24.9 | 0.050 | |
| 73 | PRS062 | Persistent Hyperplastic Primary Vitreous | 15.3 | 0.050 | |
| 74 | PTT014 | Pitt-hopkins Syndrome | 36.3 | 0.050 | |
| 75 | SZR002 | Seizures | 70.7 | 0.050 | |
| 76 | THY032 | Thyroiditis | 81.1 | 0.050 | |
| 77 | P | WLM002 | Wilms Tumor | 75.9 | 0.050 |
| 78 | XLN002 | X-linked Hypophosphatemia | 47.3 | 0.050 | |
| 79 | c | 11B001 | 11-beta-hydroxylase Deficiency | 45.4 | 0.036 |
| 80 | 21H002 | 21-hydroxylase-deficient Congenital Adrenal Hyperplasia | 26.1 | 0.036 | |
| 81 | P | 3BT001 | 3-beta-hydroxysteroid Dehydrogenase Deficiency | 40.7 | 0.036 |
| 82 | 46X010 | 46xy Partial Gonadal Dysgenesis, with Minifascicular Neuropathy | 13.2 | 0.036 | |
| 83 | ABD010 | Abdominal Wall Defect | 22.9 | 0.036 | |
| 84 | ACN001 | Acinar Cell Carcinoma | 53.2 | 0.036 | |
| 85 | P | ACR001 | Aicardi-goutieres Syndrome | 43.8 | 0.036 |
| 86 | ACR045 | Acro-pectoro-renal Field Defect | 10.2 | 0.036 | |
| 87 | c | ACR050 | Aicardi-goutieres Syndrome Type 1 | 19.8 | 0.036 |
| 88 | c | ACR051 | Aicardi-goutieres Syndrome Type 2 | 12.0 | 0.036 |
| 89 | c | ACR052 | Aicardi-goutieres Syndrome Type 3 | 9.6 | 0.036 |
| 90 | c | ACR053 | Aicardi-goutieres Syndrome Type 4 | 10.6 | 0.036 |
| 91 | c | ACR054 | Aicardi-goutieres Syndrome Type 5 | 11.0 | 0.036 |
| 92 | ADM002 | Adamantinoid Basal Cell Epithelioma | 12.4 | 0.036 | |
| 93 | ADN009 | Adenosquamous Carcinoma | 67.7 | 0.036 | |
| 94 | ADN011 | Adenoid Cystic Carcinoma | 80.0 | 0.036 | |
| 95 | ADN025 | Adenoameloblastoma | 7.6 | 0.036 | |
| 96 | ADR005 | Adrenal Carcinoma | 47.2 | 0.036 | |
| 97 | ADR015 | Adrenocortical Carcinoma | 72.9 | 0.036 | |
| 98 | ALC006 | Alcoholic Hepatitis | 71.4 | 0.036 | |
| 99 | ALL001 | Allan-herndon-dudley Syndrome | 46.0 | 0.036 | |
| 100 | AMP010 | Ampulla of Vater Carcinoma | 53.5 | 0.036 | |
| 101 | ANG001 | Angelman Syndrome | 57.8 | 0.036 | |
| 102 | ANK002 | Ankylosing Spondylitis | 88.2 | 0.036 | |
| 103 | ANK003 | Ankle Defects Short Stature | 8.0 | 0.036 | |
| 104 | ANL008 | Anal Carcinoma in Situ | 22.2 | 0.036 | |
| 105 | ANL011 | Anal Canal Carcinoma | 43.7 | 0.036 | |
| 106 | ANL013 | Anal Margin Basal Cell Carcinoma | 7.0 | 0.036 | |
| 107 | APC004 | Apocrine Adenocarcinoma | 32.7 | 0.036 | |
| 108 | ART019 | Aortic Valve Stenosis | 64.8 | 0.036 | |
| 109 | ATM003 | Autoimmune Thyroiditis | 80.9 | 0.036 | |
| 110 | ATM011 | Autoimmune Hepatitis | 80.5 | 0.036 | |
| 111 | P | ATR001 | Atrioventricular Septal Defect | 37.2 | 0.036 |
| 112 | ATR010 | Atrial Heart Septal Defect | 21.9 | 0.036 | |
| 113 | BLD008 | Bladder Carcinoma in Situ | 29.8 | 0.036 | |
| 114 | BLD033 | Bile Duct Adenoma | 39.5 | 0.036 | |
| 115 | BLD042 | Bladder Carcinoma | 78.9 | 0.036 | |
| 116 | BNP002 | Bone Epithelioid Hemangioma | 18.0 | 0.036 | |
| 117 | BRN015 | Bronchiolo-alveolar Adenocarcinoma | 44.5 | 0.036 | |
| 118 | BRN016 | Bronchogenic Carcinoma | 66.1 | 0.036 | |
| 119 | BRN050 | Branchial Arch Defects | 8.3 | 0.036 | |
| 120 | BRS013 | Borst-jadassohn Intraepidermal Carcinoma | 20.8 | 0.036 | |
| 121 | BRS048 | Breast Carcinoma | 85.7 | 0.036 | |
| 122 | BRS049 | Breast Carcinoma in Situ | 58.9 | 0.036 | |
| 123 | BRS054 | Breast Hemangioma | 18.1 | 0.036 | |
| 124 | BRS062 | Breast Secretory Carcinoma | 22.5 | 0.036 | |
| 125 | BRT016 | Bartholin's Gland Carcinoma | 19.7 | 0.036 | |
| 126 | BRT030 | Birth Defects | 53.0 | 0.036 | |
| 127 | BSC001 | Buschke-ollendorff Syndrome | 36.0 | 0.036 | |
| 128 | BSL011 | Basal Cell Carcinoma, Multiple | 13.4 | 0.036 | |
| 129 | BSL021 | Basal Cell Carcinoma, Somatic | 28.2 | 0.036 | |
| 130 | c | BSL024 | Basal Cell Carcinoma 1 | 7.1 | 0.036 |
| 131 | c | BSL025 | Basal Cell Carcinoma 2 | 1.0 | 0.036 |
| 132 | c | BSL026 | Basal Cell Carcinoma 3 | 0.0 | 0.036 |
| 133 | c | BSL027 | Basal Cell Carcinoma 4 | 0.0 | 0.036 |
| 134 | c | BSL028 | Basal Cell Carcinoma 5 | 0.0 | 0.036 |
| 135 | c | BSL029 | Basal Cell Carcinoma 6 | 0.0 | 0.036 |
| 136 | CCM004 | Cecum Carcinoma | 26.2 | 0.036 | |
| 137 | CDL003 | Caudal Regression Syndrome | 36.3 | 0.036 | |
| 138 | CHL065 | Cholangiocarcinoma | 76.5 | 0.036 | |
| 139 | CHL090 | Cholesterol Desmolase-deficient Congenital Adrenal Hyperplasia | 15.7 | 0.036 | |
| 140 | CHY002 | Chylomicron Retention Disease | 24.2 | 0.036 | |
| 141 | CLL002 | Collecting Duct Carcinoma | 50.7 | 0.036 | |
| 142 | CLN004 | Colon Carcinoma in Situ | 36.4 | 0.036 | |
| 143 | CLN017 | Colon Carcinoma | 82.7 | 0.036 | |
| 144 | CLT001 | Clitoris Cancer | 22.5 | 0.036 | |
| 145 | CNG138 | Congenital Adrenal Hyperplasia Due to Apparent Combined P450c17 and P450c21 Deficiency | 15.0 | 0.036 | |
| 146 | CNT023 | Central Nervous System Hemangioma | 16.9 | 0.036 | |
| 147 | CRB006 | Cribriform Carcinoma | 30.5 | 0.036 | |
| 148 | CRB014 | Cerebral Angioma | 21.6 | 0.036 | |
| 149 | P | CRB048 | Cerebral Cavernous Malformations | 56.5 | 0.036 |
| 150 | CRC002 | Carcinoma Arising in Nasal Papillomatosis | 17.3 | 0.036 | |
| 151 | CRC008 | Carcinoma of the Vocal Tract | 15.0 | 0.036 | |
| 152 | CRC009 | Carcinoma of Unknown Primary Site, Childhood | 5.0 | 0.036 | |
| 153 | CRT032 | Cortical Defects Wormian Bones and Dentinogenesis Imperfecta | 8.3 | 0.036 | |
| 154 | CRV002 | Cervix Uteri Carcinoma in Situ | 33.8 | 0.036 | |
| 155 | CRV040 | Cervix Carcinoma | 65.7 | 0.036 | |
| 156 | CST002 | Castleman's Disease | 56.5 | 0.036 | |
| 157 | DFC001 | Defective Apolipoprotein B-100 | 38.5 | 0.036 | |
| 158 | DRM004 | Dermatofibrosarcoma | 62.4 | 0.036 | |
| 159 | DRM014 | Dermatofibrosarcoma Protuberans | 68.0 | 0.036 | |
| 160 | DST001 | Distal Biliary Tract Carcinoma | 18.2 | 0.036 | |
| 161 | EMB004 | Embryonal Carcinoma | 82.7 | 0.036 | |
| 162 | END018 | Endometrium Carcinoma in Situ | 20.3 | 0.036 | |
| 163 | END029 | Endocervical Carcinoma | 22.0 | 0.036 | |
| 164 | END041 | Endometrial Adenocarcinoma | 78.1 | 0.036 | |
| 165 | END042 | Endometrial Carcinoma | 84.9 | 0.036 | |
| 166 | EPL017 | Epilepsy Multi-gene Panels | 15.2 | 0.036 | |
| 167 | EPT016 | Epithelioma, Self-healing, Squamous 1, Ferguson-smith Type | 16.3 | 0.036 | |
| 168 | ERL009 | Early Infantile Epileptic Encephalopathy Multi-gene Panels | 15.7 | 0.036 | |
| 169 | ESP005 | Esophagus Carcinoma in Situ | 21.5 | 0.036 | |
| 170 | ESP022 | Esophageal Carcinoma | 80.6 | 0.036 | |
| 171 | EVN001 | Evans' Syndrome | 47.8 | 0.036 | |
| 172 | EXC001 | Exocervical Carcinoma | 19.0 | 0.036 | |
| 173 | EXT018 | External Ear Basal Cell Carcinoma | 6.0 | 0.036 | |
| 174 | EXT023 | External Ear Carcinoma | 23.3 | 0.036 | |
| 175 | EYC001 | Eye Carcinoma in Situ | 20.0 | 0.036 | |
| 176 | EYL002 | Eyelid Carcinoma | 19.0 | 0.036 | |
| 177 | FLL027 | Fallopian Tube Carcinoma | 58.9 | 0.036 | |
| 178 | FML082 | Familial Partial Paralysis | 12.5 | 0.036 | |
| 179 | FML158 | Familial Hemangioma | 14.2 | 0.036 | |
| 180 | FRG002 | Ferguson-smith Tumor | 19.4 | 0.036 | |
| 181 | GBL001 | Goblet Cell Carcinoma | 17.3 | 0.036 | |
| 182 | GLL010 | Gallbladder Mucinous Carcinoma | 18.5 | 0.036 | |
| 183 | GLL019 | Gallbladder Carcinoma | 79.0 | 0.036 | |
| 184 | GST005 | Gastric Hemangioma | 9.6 | 0.036 | |
| 185 | GST022 | Gastric Pylorus Carcinoma | 7.0 | 0.036 | |
| 186 | GST024 | Gastric Fundus Carcinoma | 19.6 | 0.036 | |
| 187 | GST025 | Gastric Body Carcinoma | 9.6 | 0.036 | |
| 188 | GST041 | Gastric Cardia Carcinoma | 29.2 | 0.036 | |
| 189 | GST042 | Gastric Diffuse Adenocarcinoma | 25.0 | 0.036 | |
| 190 | P | HMC003 | Hemochromatosis | 81.0 | 0.036 |
| 191 | HMH002 | Hemihypertrophy | 40.1 | 0.036 | |
| 192 | HMN003 | Hemangioma of Spleen | 21.2 | 0.036 | |
| 193 | HMN004 | Hemangioma of Liver | 28.8 | 0.036 | |
| 194 | HMN006 | Hemangioma of Peripheral Nerve | 15.3 | 0.036 | |
| 195 | HMN007 | Hemangioma of Orbit | 17.0 | 0.036 | |
| 196 | HMN008 | Hemangioma of Subcutaneous Tissue | 19.3 | 0.036 | |
| 197 | HMN011 | Hemangioma of Intra-abdominal Structure | 12.2 | 0.036 | |
| 198 | HMN012 | Hemangioma of Lung | 55.7 | 0.036 | |
| 199 | HMN024 | Hemangioma, Hereditary | 14.0 | 0.036 | |
| 200 | HMN026 | Hemangioma, Capillary Infantile, Somatic | 34.7 | 0.036 | |
| 201 | HMN027 | Hemangioma, Capillary Infantile | 31.6 | 0.036 | |
| 202 | P | HPT023 | Hepatocellular Carcinoma | 92.1 | 0.036 |
| 203 | HPT024 | Hepatic Adenoma | 40.3 | 0.036 | |
| 204 | HRD035 | Hair Defect with Photosensitivity and Mental Retardation | 9.8 | 0.036 | |
| 205 | HST004 | Histiocytoid Hemangioma | 17.8 | 0.036 | |
| 206 | HTR004 | Heterotopia | 38.6 | 0.036 | |
| 207 | HYP178 | Hyperthermia Induced Defects | 8.3 | 0.036 | |
| 208 | c | HYW001 | Hay-wells Syndrome | 29.8 | 0.036 |
| 209 | INF027 | Infiltrative Basal Cell Carcinoma | 25.3 | 0.036 | |
| 210 | INF028 | Infundibulocystic Basal Cell Carcinoma | 13.0 | 0.036 | |
| 211 | INT013 | Intramuscular Hemangioma | 18.6 | 0.036 | |
| 212 | INT019 | Intestine Carcinoma in Situ | 19.4 | 0.036 | |
| 213 | INT077 | Intracranial Structure Hemangioma | 19.3 | 0.036 | |
| 214 | INV006 | Inverted Papilloma | 59.0 | 0.036 | |
| 215 | KDN012 | Kidney Carcinoma in Situ | 22.5 | 0.036 | |
| 216 | LCR011 | Lacrimal Gland Carcinoma | 22.8 | 0.036 | |
| 217 | LMB013 | Limb Reduction Defect | 15.0 | 0.036 | |
| 218 | LMY002 | Leiomyoma | 79.2 | 0.036 | |
| 219 | LNG003 | Lung Carcinoma in Situ | 23.2 | 0.036 | |
| 220 | LNG014 | Lung Superior Sulcus Carcinoma | 19.4 | 0.036 | |
| 221 | LNG017 | Lung Giant Cell Carcinoma | 53.0 | 0.036 | |
| 222 | LNG020 | Lung Oat Cell Carcinoma | 27.5 | 0.036 | |
| 223 | LNG032 | Lung Cancer | 84.3 | 0.036 | |
| 224 | LNG033 | Lung Carcinoma | 91.4 | 0.036 | |
| 225 | LPD009 | Lipid Storage Disease | 49.3 | 0.036 | |
| 226 | LPD011 | Lipoid Adrenal Hyperplasia | 34.7 | 0.036 | |
| 227 | LPD012 | Lipoid Congenital Adrenal Hyperplasia | 40.6 | 0.036 | |
| 228 | LRG001 | Large Cell Carcinoma | 65.1 | 0.036 | |
| 229 | LRY009 | Larynx Carcinoma in Situ | 20.7 | 0.036 | |
| 230 | LRY016 | Laryngeal Carcinoma | 80.8 | 0.036 | |
| 231 | LTR008 | Lateral Body Wall Defect | 8.3 | 0.036 | |
| 232 | LTR011 | Laterality Defects Dominant | 3.0 | 0.036 | |
| 233 | LVR003 | Liver Carcinoma in Situ | 24.4 | 0.036 | |
| 234 | MCH008 | Michelin Tire Baby Syndrome | 6.0 | 0.036 | |
| 235 | MCP006 | Mucoepidermoid Carcinoma | 72.6 | 0.036 | |
| 236 | MCR046 | Microcephaly Brain Defect Spasticity Hypernatremia | 10.9 | 0.036 | |
| 237 | MDD009 | Middle Ear Carcinoma | 19.9 | 0.036 | |
| 238 | MRK001 | Merkel Cell Carcinoma | 73.4 | 0.036 | |
| 239 | MRP002 | Morpheaform Basal Cell Carcinoma | 13.7 | 0.036 | |
| 240 | MTT001 | Metatypical Basal Cell Carcinoma | 13.4 | 0.036 | |
| 241 | NCR006 | Necrosis of Ear Ossicle | 15.0 | 0.036 | |
| 242 | NDL009 | Nodular Basal Cell Carcinoma | 29.5 | 0.036 | |
| 243 | NNH002 | Non-a-e Hepatitis | 30.5 | 0.036 | |
| 244 | P | NRF002 | Neurofibromatosis | 86.3 | 0.036 |
| 245 | NRF007 | Neurofibroma | 61.8 | 0.036 | |
| 246 | NRM004 | Neuroma | 61.1 | 0.036 | |
| 247 | NRN001 | Neuroendocrine Carcinoma | 73.9 | 0.036 | |
| 248 | NSL007 | Nasal Cavity Carcinoma in Situ | 20.1 | 0.036 | |
| 249 | NVS003 | Nevus | 61.5 | 0.036 | |
| 250 | OCH002 | Ochoa Syndrome | 28.7 | 0.036 | |
| 251 | ODN006 | Odontoma | 21.9 | 0.036 | |
| 252 | OLL001 | Ollier Disease | 58.8 | 0.036 | |
| 253 | OVR022 | Ovary Mixed Epithelial Carcinoma | 17.6 | 0.036 | |
| 254 | OVR074 | Overgrowth Radial Ray Defect Arthrogryposis | 8.3 | 0.036 | |
| 255 | PLM009 | Pleomorphic Adenoma Carcinoma | 54.7 | 0.036 | |
| 256 | PLY012 | Polyhydramnios | 45.1 | 0.036 | |
| 257 | PLY062 | Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy | 17.9 | 0.036 | |
| 258 | PNC008 | Pancreatic Endocrine Carcinoma | 48.4 | 0.036 | |
| 259 | PNC036 | Pancreatic Carcinoma | 82.4 | 0.036 | |
| 260 | PNC044 | Pancreatitis | 87.9 | 0.036 | |
| 261 | PNS002 | Penis Carcinoma in Situ | 23.2 | 0.036 | |
| 262 | PNS009 | Penis Carcinoma | 26.0 | 0.036 | |
| 263 | PPL002 | Papillary Carcinoma | 77.9 | 0.036 | |
| 264 | P | PPL005 | Papillary Renal Cell Carcinoma | 67.4 | 0.036 |
| 265 | PPL022 | Papilloma | 76.9 | 0.036 | |
| 266 | PRC025 | Precocious Puberty, Gonadotropin-dependent | 11.2 | 0.036 | |
| 267 | PRC030 | Precocious Puberty, Male | 32.6 | 0.036 | |
| 268 | PRL014 | Paralytic Squint | 23.3 | 0.036 | |
| 269 | PRN020 | Paranasal Sinus Cancer | 26.8 | 0.036 | |
| 270 | PRS031 | Prostate Carcinoma in Situ | 28.2 | 0.036 | |
| 271 | PRS041 | Prostate Carcinoma | 87.1 | 0.036 | |
| 272 | PRT001 | Partial Fetal Alcohol Syndrome | 28.3 | 0.036 | |
| 273 | PRT007 | Partial of Retinal Vein Occlusion | 15.7 | 0.036 | |
| 274 | PRT010 | Parathyroid Carcinoma | 67.6 | 0.036 | |
| 275 | PRT015 | Partial Third-nerve Palsy | 17.1 | 0.036 | |
| 276 | PRT047 | Partial Agenesis of Corpus Callosum | 21.5 | 0.036 | |
| 277 | PRT048 | Partial Atrioventricular Canal | 6.0 | 0.036 | |
| 278 | PRT049 | Partial Deletion of Y | 8.3 | 0.036 | |
| 279 | PTN001 | Patent Foramen Ovale | 52.9 | 0.036 | |
| 280 | PTT008 | Pituitary Carcinoma | 51.7 | 0.036 | |
| 281 | RCT010 | Rectum Carcinoma in Situ | 20.9 | 0.036 | |
| 282 | RCT021 | Rectum Cancer | 27.0 | 0.036 | |
| 283 | RDC003 | Red Cell Phospholipid Defect with Hemolysis | 10.6 | 0.036 | |
| 284 | RDC004 | Reductional Transverse Limb Defects | 3.0 | 0.036 | |
| 285 | P | RNL014 | Renal Cell Carcinoma | 90.6 | 0.036 |
| 286 | RNL018 | Renal Pelvis Carcinoma | 24.2 | 0.036 | |
| 287 | RNL031 | Renal Agenesis Meningomyelocele Mullerian Defect | 8.3 | 0.036 | |
| 288 | RTR004 | Retroperitoneum Carcinoma | 18.4 | 0.036 | |
| 289 | SBC007 | Subacute Thyroiditis | 60.9 | 0.036 | |
| 290 | SBC013 | Sebaceous Basal Cell Carcinoma | 12.2 | 0.036 | |
| 291 | SBG002 | Subglottic Angioma | 16.4 | 0.036 | |
| 292 | SCN013 | Scn1a-related Intractable Infantile Partial Seizures | 11.3 | 0.036 | |
| 293 | SCR010 | Scrotal Angioma | 16.6 | 0.036 | |
| 294 | SCR014 | Scrotum Basal Cell Carcinoma | 6.6 | 0.036 | |
| 295 | SCR016 | Scrotal Carcinoma | 17.7 | 0.036 | |
| 296 | SCR020 | Sacral Defect with Anterior Meningocele | 13.9 | 0.036 | |
| 297 | SHL003 | Shoulder Girdle Defect Mental Retardation Familial | 8.3 | 0.036 | |
| 298 | SKL011 | Skeletal Defects, Genital Hypoplasia, and Mental Retardation | 12.3 | 0.036 | |
| 299 | SKN003 | Skene Gland Carcinoma | 19.7 | 0.036 | |
| 300 | SKN012 | Skin Carcinoma in Situ | 37.7 | 0.036 | |
| 301 | SKN015 | Skin Carcinoma | 57.0 | 0.036 | |
| 302 | SKN018 | Skin Hemangioma | 20.2 | 0.036 | |
| 303 | SLC008 | Selective T-cell Defect | 12.8 | 0.036 | |
| 304 | SNS014 | Sinusitis | 74.4 | 0.036 | |
| 305 | SPN032 | Spindle Cell Carcinoma | 62.5 | 0.036 | |
| 306 | SQM006 | Squamous Cell Carcinoma | 90.4 | 0.036 | |
| 307 | STM003 | Stomach Carcinoma in Situ | 23.9 | 0.036 | |
| 308 | STM005 | Stomach Carcinoma | 57.0 | 0.036 | |
| 309 | P | STR022 | Stargardt Disease | 39.2 | 0.036 |
| 310 | SWT001 | Sweat Gland Carcinoma | 56.1 | 0.036 | |
| 311 | P | SYN001 | Syndactyly | 58.5 | 0.036 |
| 312 | SYN004 | Synovial Angioma | 16.9 | 0.036 | |
| 313 | c | SYN020 | Syndactyly Type 2 | 12.7 | 0.036 |
| 314 | THR013 | Thoracic Outlet Syndrome | 33.0 | 0.036 | |
| 315 | THY038 | Thyroid Hormone Organification Defect Iia | 10.2 | 0.036 | |
| 316 | THY053 | Thyroid Hormone Plasma Membrane Transport Defect | 9.3 | 0.036 | |
| 317 | THY057 | Thyroid Hormonogenesis Defect I | 10.3 | 0.036 | |
| 318 | TKY001 | Takayasu's Arteritis | 67.1 | 0.036 | |
| 319 | P | TMT001 | Timothy Syndrome | 40.9 | 0.036 |
| 320 | TRC002 | Trachea Carcinoma in Situ | 21.2 | 0.036 | |
| 321 | TRG010 | Trigonomacrocephaly Tibial Defect Polydactyly | 8.3 | 0.036 | |
| 322 | TRN020 | Turner Syndrome | 73.3 | 0.036 | |
| 323 | TRT004 | Tourette Syndrome | 72.1 | 0.036 | |
| 324 | TTL002 | Total Third-nerve Palsy | 7.6 | 0.036 | |
| 325 | TTL004 | Total Iodide Organification Defect | 24.3 | 0.036 | |
| 326 | URC002 | Urea Cycle Disorder | 44.2 | 0.036 | |
| 327 | UTR009 | Uterus Carcinoma in Situ | 20.6 | 0.036 | |
| 328 | VLV002 | Vulva Basal Cell Carcinoma | 14.5 | 0.036 | |
| 329 | VRR004 | Verrucous Carcinoma | 63.3 | 0.036 | |
| 330 | WLF002 | Wolf-hirschhorn Syndrome | 42.1 | 0.036 | |
| 331 | WLM003 | Wilms Tumor and Radial Bilateral Aplasia | 11.3 | 0.036 | |
| 332 | c | WLM005 | Wilms Tumor 2 | 14.1 | 0.036 |
| 333 | XLN018 | X-linked Creatine Deficiency | 22.0 | 0.036 | |
| 334 | ZP7001 | Zap70-related Severe Combined Immunodeficiency | 18.6 | 0.036 |